Evolving practice: X-linked agammaglobulinemia and lung transplantation

S. Barnes, S. Kotecha, J. A. Douglass, E. Paul, F. Hore-Lacey, R. Stirling, G. I. Snell, G. P. Westall

Research output: Contribution to journalArticleOtherpeer-review

13 Citations (Scopus)


X-linked agammaglobulinemia (XLA) is a rare primary humoral immunodeficiency syndrome characterized by agammaglobulinemia, recurrent infections and bronchiectasis. Despite the association with end-stage bronchiectasis, the literature on XLA and lung transplantation is extremely limited. We report a series of 6 XLA patients with bronchiectasis who underwent lung transplantation. Short-term outcomes were excellent however long-term outcomes were disappointing with a high incidence of pulmonary sepsis and chronic lung allograft dysfunction (CLAD). This case series examines six patients with X-linked agammaglobulinemia and tracks their post-lung transplant course to highlight the challenges of immunosuppression and infection as well as chronic lung allograft dysfunction in these patients.

Original languageEnglish
Pages (from-to)1110-1113
Number of pages4
JournalAmerican Journal of Transplantation
Issue number4
Publication statusPublished - 1 Apr 2015


  • clinical research
  • immune modulation
  • immunosuppression
  • immunosuppressive regimens
  • lung transplantation
  • practice
  • pulmonology, rejection: chronic

Cite this